Consumer Driven Health Care

The savings are not yet realized, says the Congressional Budget Office, which projects a 10-year cumulative savings of $161 billion from the phased-in drug negotiation, as well as a rebate for price increases above the inflation rate.

The $35 insulin cap reduces out-of-pocket costs for those with health savings accounts but new policies are needed to improve access to affordable insulin among commercially insured patients, says a new study.

Benefytt Technologies, operating under various names such as Health Insurance Innovations, used aggressive marketing in a scheme to lure consumers in search of Obamacare health plans, says the Federal Trade Commission.

Q2 is here and it's time for a benefits checkup: Do the benefits you offer truly provide for all aspects of an employee's wellbeing?

The city of Baltimore, which paid more than $11 million in 2023 for diabetes medications through its self-funded plan, is suing the drug manufacturers, for allegedly conspiring to artificially hike the price of insulin.

On Tuesday, the justices will hear arguments on whether to revoke mifepristone's approval and curtail its availability because the FDA imposed strict safety limits on who could prescribe and distribute it when it gave its approval.